The Shotlee Journal
Browse Shotlee articles about Health & Wellness.
Showing 9 / 258 Health & Wellness articles
New data shows many patients cycle on and off GLP-1 medications. Discover why this approach may hinder long-term health and why tracking is essential.
Rebel Wilson's transformation is more than a celebrity headline; it's a masterclass in metabolic health. Discover the role of GLP-1s, the science of consistency, and why moderation beats intensity.
While Ozzy Osbourne received a posthumous lifetime achievement award at the Brit Awards, online focus shifted to Kelly Osbourne's appearance with cruel comments. In an emotional Instagram post, Kelly called out the lack of compassion during her hardest time. This echoes prior backlash accusing her of Ozempic use amid grief.
Daily tasks like banking and food delivery are fully digital, yet healthcare remains outdated. In Nigeria, 47.7% of educated adults self-medicate antibiotics, driving antimicrobial resistance deaths. Digital platforms and GLP-1 weight loss programs offer seamless, compliant solutions.
As the new year begins, many focus on health objectives like shedding pounds or improving nutrition. Calocurb offers a natural, over-the-counter alternative to GLP-1 injections for appetite control. Discover its workings, dosage, side effects, and pricing to see if it fits your lifestyle.
After struggling with obesity for decades despite top advice, the author found lasting success by focusing on bodily mechanisms like insulin control. Key strategies include prioritizing fiber-rich foods, avoiding processed items, and ensuring protein in every meal. Health tracking apps like Shotlee can help monitor progress along the way.
The trend of using GLP-1 medications like Ozempic for weight loss has led to a phenomenon known as 'Ozempic face,' marked by sunken eyes and defined facial features. Celebrities and regular individuals alike have embraced these drugs, with over 10% of Americans reportedly using them in 2025. From Oprah to Elon Musk, several high-profile figures have experienced noticeable changes in their appearances.
The future of GLP-1 drugs for weight loss involves daily pills, smartphone apps for dose management, and easy access through telehealth, mirroring consumer goods like streaming services. As Novo Nordisk and Eli Lilly prepare pill versions, the obesity market could expand to $150 billion by the next decade. This shift emphasizes convenience, affordability, and lifestyle integration, but raises concerns about medical oversight and safety.
The food industry is facing a significant challenge due to the rise of weight-loss drugs like Ozempic, which are altering consumer preferences. Companies are now innovating to cater to a new landscape of health-conscious consumers.
